California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on August 11, 2026

Aug. 11, 2026

Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Aug. 11, 2026

PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101

Indeterminate GlobeNewswire

Aug. 11, 2026

Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights

Indeterminate GlobeNewswire

Aug. 11, 2026

Flyte Partners with The Nucleus Network for Inaugural Flagship Founder & Investor Event

Indeterminate GlobeNewswire

Aug. 11, 2026

Clearmind Medicine Announces Positive Permeation Results for Intranasal MEAI Formulation, Supporting Enhanced Nasal Retention Without Compromising Drug Delivery

Indeterminate GlobeNewswire

Aug. 11, 2026

Moody’s Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy

Indeterminate GlobeNewswire

Aug. 11, 2026

Nu-Tek BioSciences erhält zum dritten Mal in Folge die EcoVadis-Bronzeauszeichnung und baut seine Position als nachhaltiger Partner der Biopharmaindustrie weiter aus

Indeterminate GlobeNewswire

Aug. 11, 2026

Nu-Tek BioSciences Earns EcoVadis Bronze Rating for Third Consecutive Year, Strengthening Sustainable Biopharmaceutical Supplier Status

Indeterminate GlobeNewswire

Aug. 11, 2026

Nu-Tek BioSciences obtient la Médaille de bronze décernée par EcoVadis pour la troisième année consécutive, consolidant ainsi son statut de fournisseur biopharmaceutique respectueux de l’environnement

Indeterminate GlobeNewswire

Aug. 11, 2026

Noah Medical Announces Galaxy™ II, the Next Dimension in Robotic-Assisted Bronchoscopy

Indeterminate GlobeNewswire

Aug. 11, 2026

LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 11, 2026

NovelMed Advances Its Ocular Program, Highlighting the Potential of a Single Therapy Across Multiple Retinal Diseases

Indeterminate GlobeNewswire

Aug. 11, 2026

Gibson Oncology Announces First Patient Completes Initial Treatment Cycle in Phase II Trial of LMP744 for Recurrent Glioblastoma

Indeterminate GlobeNewswire

Aug. 11, 2026

Aqua-Tots Opens First Québec Location, Expanding Access to Swim Lessons in Île-Perrot

Indeterminate GlobeNewswire

Aug. 11, 2026

Theriva™ Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results

Indeterminate GlobeNewswire

Aug. 11, 2026

IMUNON Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 11, 2026

Protara Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update

Indeterminate GlobeNewswire

Aug. 11, 2026

YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute

Indeterminate GlobeNewswire

Aug. 11, 2026

SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma

Indeterminate GlobeNewswire

Aug. 11, 2026

Frishantic Introduces New Magnesium Complex for Women, Combining Seven Magnesium Forms with L-Theanine and Vitamin B6

Indeterminate GlobeNewswire